Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Poor Ovarian Response peptide trials
4 selected ClinicalTrials.gov records carrying the official condition label Poor Ovarian Response. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
4 selected records.
2 profiles.
2013–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 36 selected PubMed records and 12 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Poor Ovarian Response unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01732068
PeptideScanner retained ClinicalTrials.gov record NCT01732068 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 9, 2013
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01732094
PeptideScanner retained ClinicalTrials.gov record NCT01732094 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 9, 2013
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01816321
PeptideScanner retained ClinicalTrials.gov record NCT01816321 at 2026-11-15T22:03:26.540Z. Its registry update date was 2016-06-23, and PeptideScanner's reviewed identity mapping was ganirelix.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 23, 2016
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Triptorelin · 2026-09-11
ClinicalTrials.gov record NCT07816562
Recruiting at the retained observation.
Open attributed record →Ganirelix · 2016-06-23
ClinicalTrials.gov record NCT01816321
Completed at the retained observation.
Open attributed record →Triptorelin · 2013-05-09
ClinicalTrials.gov record NCT01732068
Completed at the retained observation.
Open attributed record →Triptorelin · 2013-05-09
ClinicalTrials.gov record NCT01732094
Completed at the retained observation.
Open attributed record →